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Abstract
Background: Despite the Government acting quickly to reassure parents about MMR safety
following the publication of the 1998 paper by Wakefield and colleagues, MMR uptake declined.
One of the reasons suggested for this decline is a loss of public trust in politicians and health
professionals. The purpose of this analysis was to examine parents' views on the role the media,
politicians and health professionals have played in providing credible evidence about MMR safety.
Methods: A qualitative focus group study conducted with parents living in Central Scotland.
Eighteen focus groups were conducted with 72 parents (64 mothers and 8 fathers) between
November 2002 and March 2003. Purposive sampling was used to ensure maximum variation
among parents.
Results: In the period after the MMR controversy, parents found it difficult to know who to trust
to offer balanced and accurate information. The general consensus was that politicians were
untrustworthy in matters of health. The motives of primary health care providers were suspected
by some parents, who saw them as having a range of vested interests (including financial incentives).
Among the sources of evidence seen by some parents as more credible were other parents, and
Andrew Wakefield who was viewed as an important whistle-blower and champion of ordinary
parents.
Conclusion: The provision of accurate information is only one aspect of helping parents make
immunisation decisions. Establishing and maintaining trust in the information provided is also
important. The MMR controversy may provide useful lessons for health professionals about trust
and credibility that may be generalisable to future health controversies.
Background
In Britain in October 1988, the combined measles,
mumps, and rubella (MMR) vaccine was introduced into
the routine childhood immunisation programme, replac-
ing the monocomponent measles vaccine. By the early
1990s, MMR coverage for 2-year-old children exceeded
90% nationally and cases of measles fell to historically
low levels [1]. In 1998 Dr. Andrew Wakefield and co-
authors published a case series of 12 children in which
they raised the possibility of a link between the MMR vac-
cine, autism and inflammatory bowel disease [2]. Despite
the fact that the study received little support from the sci-
entific community [3-5] and that the British Government
acted quickly to reassure parents of the safety of the vac-
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cine, these assertions led to a decline in MMR uptake.
MMR coverage fell as low as 58% in some parts of the UK,
and subsequent outbreaks of measles and mumps
occurred [6,7]. Unlike many other health scares that are
short-lived, stories about the safety of the MMR vaccine
made headline news for some years, and there has been
continuing interest in the issue from the media, politi-
cians, health professionals, and parents alike.
A number of recent studies have explored how the contro-
versy has been communicated to parents by health profes-
sionals and others, and their views of the reliability and
trustworthiness of these sources of information. One
qualitative study found that parents have not been con-
vinced by the Department of Health's reassurances that
MMR is the safest and best option, and it has been found
that parents consider the information provided by health
professionals to be biased [8]. For example they are aware
that GPs need to reach immunisation targets and receive
financial incentives to do so under the Childhood Immu-
nisation Payments system [9]. Some GPs have criticised
the immunisation payment system on the grounds that it
increases parental distrust [10].
Attempts to achieve balanced reporting in the media may
actually introduce bias, however unintentionally. In the
UK, the presentation of both sides of the MMR debate in
the media created the misleading impression that the evi-
dence for the link with autism was as substantial as the
evidence against [11]. It has also been suggested that the
huge amount of media coverage has led parents to con-
clude that there must be some truth in the suggestion that
MMR could be harmful [12]. However, communicating
risk effectively to the public is about more than providing
information [13]. The perceived trustworthiness of the
sources providing information, including the Department
of Health, and wider public scepticism about Government
pronouncements on health following the BSE outbreak,
also play a part [14].
Public distrust of health information may also have been
heightened by Government's handling of the BSE, foot
and mouth crises and salmonella and E. coli outbreaks,
during which Government agencies responsible for food
safety were perceived to have put the interests of food pro-
ducers before those of consumers [15]. This growing pub-
lic scepticism of the Government's trustworthiness in
safeguarding public health provides the backdrop against
which parents are expected to weigh the risks and benefits
of MMR immunisation.
As well as raising issues about the credibility of organisa-
tions, the MMR controversy has been unusual in high-
lighting the contribution of specific individuals. For
example, Burgess et al. refer to the role of the media in pre-
senting Dr. Andrew Wakefield as "a lone voice against the
establishment in a David and Goliath struggle"[14].
Wakefield remains in the public eye as a result of the Gen-
eral Medical Council decision in June 2006 to charge him
with serious professional misconduct. Another key figure,
Dr. Viera Scheibner, a public opponent of vaccination has
toured North America, Europe and Australasia claiming
that vaccines are ineffective and dangerous. These individ-
uals have often been presented as "whistleblowers", or as
having the best interests of parents and children at heart
in apparent contrast to 'uncaring' scientists, and their
positioning as 'independent' scientists may have made
their views more credible to parents than those of GPs,
epidemiologists or politicians who some assert, have their
own vested interests [16].
Given this background, it is perhaps not surprising that it
has been difficult to build public trust in MMR. Experts
suggest the battle for public trust needs to be based on a
better understanding of the nature of public concern [17],
and that the trustworthiness of various sources of infor-
mation appears to be key [18]. This study offers a unique
insight into the debate about MMR and public trust by
exploring opinions from an extensive range of parents and
by explicitly examining the precise nature of their con-
cerns about MMR safety.
Methods
Sampling and recruitment
Eighteen focus groups were conducted with parents living
in Central Scotland between November 2002 and March
2003. Purposive sampling was used to obtain a diverse
sample of parents in terms of age, socio-economic circum-
stances, likely views about vaccination, and family cir-
cumstances, including first-time mothers, more
experienced mothers, single fathers, and parents with
multiple social problems. The sample also included par-
ents with a range of vaccine decision-making outcomes,
including parents who had fully immunised, opted for
single vaccines, rejected MMR, and rejected all vaccina-
tions. Two additional groups were conducted with parents
who had autistic children and with parents who had an
immune-compromised child following chemotherapy
(see Table 1). Following pilot work, the focus groups were
held with small groups of between three and five people
to allow each parent enough time to express their views
and opinions and to facilitate later identification of indi-
viduals.
Data collection and analysis
A topic guide for the discussions was developed through
pilot work. The guide included parents' understanding of
the evidence about the safety of the MMR vaccine and
their perceptions of the role that the media, politicians,
and health professionals have played in the controversy.BMC Public Health 2007, 7:42 http://www.biomedcentral.com/1471-2458/7/42
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Table 1: Participants in the focus groups
Group number and brief description Participants' pseudonyms (ages of children, vaccine status)
G1 NCT group in affluent area Trudie (girl 8 yrs/girl 7 mths, both complete)
Violet (girl 2 yrs, partial)
Mel (boy 4 yrs, complete/girl 15 mths, partial)
G2 First time mothers Joanne (boy 5 mths, complete)
Elaine (girl 4 mths, complete)
Louise (boy 5 mths, complete)
Beathan (girl 6 mths, complete)
G3 Ante-natal group with second time mothers Sian (stepson 4 yrs, other/8 mths pregnant)
Dawn (boy 4 yrs/boy 3 yrs, both partial)
Ruth (boy 1 yr, complete)
Beatrice (boy 18 mths, partial)
Iona (boy 12 yrs/girl 7 yrs, girl 5 yrs/boy 3 yrs, all complete)
G4 Low MMR uptake area in deprived area Joan (girl 20 mths, complete)
Sheila (girl 10 yrs/girl 3 yrs/boy 21 mths, all complete)
Alan (boy 2 yrs, partial)
G5 High uptake area in affluent area Fiona (girl 6 yrs/boy 5 mths, both complete)
Alison (boy 15 mths, partial)
Lauren (boy 14 mths, partial)
Cassie (girl 3 yrs/boy 9 mths, both complete)
Karen (girl 7 yrs/girl 4 yrs/boy 4 mths, all complete)
Anna (girl 7 yrs, complete/boy 4 yrs, partial/girl 3 yrs, partial/girl 14 mths partial)
G6 Low MMR uptake area in deprived area Cathy (girl 3 yrs/boy 2 yrs, both complete)
Bob (boy 3 yrs/boy 7 mths, both complete)
Ella (boy 5 yrs, partial)
Helen (girl 4 yrs/boy 2 yrs, complete)
G7 High MMR uptake area in deprived area Tracy (boy 10 yrs/girl 4 yrs/girl 2 yrs, all complete)
Samantha (boy 16 mths, complete)
Lydia (boy 6 yrs, complete)
Angie (boy 5 yrs/boy 18 mths, both complete)
Mary (girl 5 yrs, complete)
G8 Young single mothers living in deprived area Kate (boy 2 yrs, complete)
Margaret (boy 2 yrs, partial)
Lisa (girl 23 mths, complete)
Ann (boy 6 mths, complete)
Lynne (boy 13 mths, complete)
Natalie (boy 15 mths, complete)
Ros (boy 20 mths, complete)
Lucy (15 boy 11 wks, complete)
G9 First-time mothers living in affluent area Rhona (boy 11 wks, complete)
Catrina (girl 11 wks, complete)
Judith (girl 11 wks, complete)
Charlotte (girl 5 mths, complete)
Celia (girl 6 mths, complete)
G10 Single fathers in deprived area William (12 yrs,/girl 5 yrs, both complete)
Kenny (boy 3 yrs other/boy 3 mths, complete)
Robert (girl 17 yrs/boy 6 yrs, both complete)
G11 Parents with multiple parenting problems in deprived 
area
Sheena (girl 7 yrs/boy 6 yrs/boy 2 yrs, all complete)
Michelle (boy 2 yrs/girl 6 mths, both complete)
Patsy (twin boys 2 yrs both complete/boy 2 mths too young), Frank (as far Patsy)
G12 Single vaccine group (Parents who opted to immunise 
their child with separate measles, mumps and rubella 
vaccines)
Dave (girl 7 yrs complete/girl 21 mths, single)
Jenny (boy 2 yrs, single)
Joe (boy 2 yrs, single)
G13 Parents who had rejected MMR Sue (boy 6 yrs, complete/boy 4 yrs, partial/boy 13 mths, complete),
Aleena (girl 5 yrs/girl 3 yrs/girl 5 mths, partial)
Hannah (boy 4 yrs/boy 2 yrs, partial)
G14 Parents who had rejected all immunisation Molly (boy 5 yrs/boy 2 yrs)
Kitty (boy 6 yrs/boy 4 yrs/boy 2 yrs)
Lola (boy 6 yrs/boy 4 yrs/boy 2 yrs)
Debbie (boy 5 yrs/boy 3 yrs/girl 23 mths/girl 4 wks)
All none
G15 Parents of an autistic child Lesley (complete) Dianna & Jacqueline (partial) The precise ages of children omitted to protect their identity -all 
boys aged between 4 and 7 yrs)
G16 Parents of an autistic child Stella, Alison, Caroline (all partial) The precise ages of children omitted to protect their identity -all boys aged 
between 4 and 9 yrs)
G17 Parents of an immunocompromised child Sally (girl 9 yrs) Rebecca (girl 8 yrs) Pamela (girl 8 yrs) all complete
G18 Parents of an immunocompromised child Jill (girl 14 yrs), Cara (girl 8 years), Jessie (boy 16 yrs) all complete
Key:
Complete: parents whose children had received all the recommended vaccines for their age in the Childhood Immunisation Programme.
Partial: parents whose children who had fallen behind the recommended schedule with some vaccines, and parents who had decided not to have 
one or more of the recommended vaccines in the programme.
Single: Parents who had opted for the single measles, mumps or rubella vaccines instead of MMR.
None: Parents who did not plan to immunise their children with any of the recommended vaccines.
Other: Parents who did not know the immunisation status of their child.BMC Public Health 2007, 7:42 http://www.biomedcentral.com/1471-2458/7/42
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The discussions lasted between one and two hours and
were facilitated by SH. To enable systematic comparisons
to be made across the large amounts of data, each tran-
script was checked and imported into NVivo 2.0. Data
were thematically coded and, following the principle of
the constant comparative method, and rigorous analysis,
[19] each transcript was repeatedly re-examined and cross-
compared to identify common themes and explore par-
ents' underlying reasoning. Once all the relevant extracts
of data had been retrieved and checked we started to
develop a coding frame around which to examine parents'
concerns and views about MMR safety. Particular atten-
tion was paid to deviant or contradictory cases [20] and to
group dynamics using field note observations [21]. One
of the advantages of using focus group methods is that it
can generate rich and dynamic data by encouraging dis-
cussion between group members. However the large
amount of data generated has meant that it was neither
feasible, nor desirable, to present all the main themes
emerging from the data in one paper. Findings on the
other two main themes, people's understandings of the
vaccine-preventable diseases and parental concerns about
"vaccination overload", have been reported elsewhere
[22,23]. The sometimes chaotic nature of focus group
conversation and the need to balance the group picture
against the voices of individuals make reporting focus
group data particularly challenging. To report the data in
this paper we have mainly selected concise quotes attrib-
utable to an individual, but during analysis have been
mindful of group effect and the fact that all conversation
is influenced by the context in which it is generated [24].
Ethical approval for the study was obtained from the Glas-
gow University Ethics Committee for non clinical research
involving human subjects.
Results
Eighteen focus groups were conducted with a range of par-
ents, including 64 mothers (age range 15 to 53 years,
mean age 32 years), and eight fathers (age range 31 to 51
years, mean age 39 years). In relation to the credibility of
sources of evidence or information on the risks of MMR,
five main bodies were identified: other parents; the
media; politicians; health care professionals; and Andrew
Wakefield himself. These are each considered in turn.
1. Other parents as credible sources of information on the 
risks of MMR
The parents that took part in this study had a range of
views about immunisation and had made different deci-
sions about the MMR vaccine, but across all the groups the
general perception was that the evidence of a causal link
between MMR and autism was not convincing at present,
but that in time further evidence could come to light to
show that MMR is damaging for some children. In the
meantime, participants felt that the evidence from the par-
ents who believed that MMR harmed their child could not
be discounted:
Trudie: I just don't think enough research has been done really,
one way or the other, to say whether it is completely safe.
Mel: I still feel as if there is something underlying, something
there, you know these children were they (interrupted)
Violet: You know though that these parents weren't just mak-
ing it up, I don't think, you know.
Mel: No, I know.
Violet: I think to say there is no evidence that it causes harm,
is not comforting, because that just means there has not been
the research done on it. You could say that about virtually any-
thing practically.
Trudie: That's true.
(G1 NCT affluent area group)
The stories of other parents were viewed as being more
impartial as they were seen to have no "hidden agenda",
and their stories were easy to relate to: "...You know where
you are with other parents. They don't have any reason to make
things up or like any hidden agenda so to speak, so you feel you
can believe other parents". (Patsy: G11 Parents with multi-
ple parenting problems). In this respect these anecdotal
accounts from other parents appeared to carry as much, if
not more, weight than either evidence from epidemiolog-
ical studies or assurances from politicians and public
health officials. Parents could understand other parents'
concerns and could assess their credibility. This was not
the case with research studies, which many participants
felt ill-equipped to assess for themselves.
2. The credibility of the media as a source of evidence
Some participants stated that they found it difficult to dis-
tance themselves from the debate, and (confirming the
importance of other parents as credible sources of evi-
dence) stated that they felt particularly drawn to newspa-
per stories that involved real life people. For example,
"... I think there's a sense that there's a kinship with other
parents that you just don't have with, you know, doctors...
And I think as well, you know, that the evidence that scien-
tists use, it's just stuff that just goes in and out your ears.
You just can't comprehend it. It's not written for parents,
and then when they do write it for parents you just wonder,
you know, what their motives are because there are so many
big players, so many people with their own interests that it's
easier to believe other parents. You want to believe other
parents."BMC Public Health 2007, 7:42 http://www.biomedcentral.com/1471-2458/7/42
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(Dave: G12 Single vaccine group)
Nonetheless parents' views on the role of the media varied
widely. Some viewed journalists as scaremongers, whilst
others thought of them as valuable information providers.
For example, one father considered that: "...the newspapers
are trying to let the everyday people know the inside story"
(Frank: G11 Parents with multiple parenting problems).
However, it was more common for parents to speak nega-
tively about the media's involvement in the MMR debate.
One mother stated angrily that: "...the media have a respon-
sibility to stop just taking bits of research and throwing it into
the press to alarm us" (Iona: G3 Ante-natal group). Parents
also felt that health stories, especially those involving chil-
dren, are of huge interest to the general public and that the
media are acutely aware of this fact. A few parents com-
plained that the media presented the evidence in such a
way that it was difficult to derive clear messages about the
safety of MMR. In particular, they criticized the tendency
to place scientific and anecdotal evidence alongside each
other, in an attempt to create balance, but in reality this
left some parents confused. The high level of media atten-
tion paid to the debate also appeared to have influenced
parents' assessment of the evidence. It was implied on sev-
eral occasions that the fact that so much attention had
been afforded to MMR was on its own evidence that MMR
is unsafe: "...there's no smoke without fire" (Margaret: G8
Young single mothers group).
3. The credibility of politicians as a source of evidence
The general consensus among parents was that politicians
were untrustworthy in matters of health. Parents recalled
the previous government's handling of the BSE crisis in
the 1990s when they felt that the public had been misin-
formed. One particular similarity was mentioned; the role
of politicians' own children. The image of John Gummer,
a former Minister of Agriculture, feeding his daughter a
hamburger in 1990 to show that British beef was safe was
mentioned by parents as symbolising the Government's
handling of the BSE crisis. Parents drew a parallel with UK
Prime Minister Tony Blair refusing to confirm in 2001
whether his baby son Leo had had MMR. This was dis-
cussed within many of the groups and parents often
debated at length the rights and wrongs of Blair's decision
not to disclose this information. For example, one mother
considered: "I don't really think it is an issue of the baby's pri-
vacy, either he has had it, or not... He should come out and say"
(Molly: G14 Parents who had rejected immunisation
group). A father agreed: "The fact that he didn't disclose that
information has put fear into parents... He may be pushing a
programme that he doesn't believe in" (Kenny: G10 Single
fathers group). For others, however the pressure to immu-
nise perhaps suggested "nanny-state" politics: "... It's like a
metaphor for the way the government treats the public. 'I know
what's best for you – have a burger', sort of thing" (Sue: G13
Parents who had rejected MMR). Parents were often dis-
missive of phrases such as 'no proven risk,' and 'minimal
risk,' and of official messages that MMR is safe, and
appeared to interpret such assurances of vaccine safety as
meaning that experts are not aware of any risk 'at the
moment'. For example, one woman said: "throwing blanket
statements at you, it's safe, there's no proven risk just doesn't
reassure you... it reeks of all the other health scare scandals.
Where we were told, there is not a problem, not a problem- oh
whoop! There is a problem." (Dawn: G3 Ante-natal group
with second time mothers). The general view expressed by
parents was that politicians serve their own and their
party's interests before that of the public.
4. Health care professionals as sources of evidence on 
MMR
Parents' views on the role that health professionals were
felt to have played were mixed and highlighted some con-
cerns about the objectivity of GPs and others. The
dilemma that many parents appeared to face was one of
knowing who to trust to give them impartial advice. One
mother of a boy with autism asked:
"What do you do as a parent? You don't know who to trust.
Because these are the people- you're meant to trust your doc-
tor implicitly and yet people are saying well, you know,
they're getting paid for having so many people vaccinated
and all this, and you start thinking 'well... who's got my
wee boy's best interests at heart' "
(Lesley: G15 Parents of a child with autism)
Similarly, another mother questioned the extent to which
parents can rely on health professionals to give them
impartial advice. She said that she felt: "...suspicious of some
of them, I just sort of don't know their motives, so you know,
that does concern me, because you know is there profit involved
in it?" (Helen: G6 Low MMR uptake area group). Central
to this dilemma seemed to be parents' increased aware-
ness that GPs receive payments for meeting Government
immunisation targets. A common theme was that parents
did not know to what extent their own GP or health visitor
was acting in their child's best interest, as opposed to act-
ing in their role as an advocate of public health policy. As
one mother put it: "they are part of the system of dispensing
it; they're not there to question." (Sue: G13 Parents who had
rejected MMR).
As for health visitors, when they sounded too resolute
about the safety of MMR, some parents questioned their
motives and knowledge; conversely when they sounded
more vague, some parents interpreted this as concern that
MMR is unsafe. Several of the parents who had either
decided to delay, or opted not to have MMR, spoke of
their health visitors applying unwanted pressure and inBMC Public Health 2007, 7:42 http://www.biomedcentral.com/1471-2458/7/42
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some cases ostracising them for not complying with the
recommended vaccines. Some of the parents who had
opted to have single measles, mumps and rubella vac-
cines, talked about feeling 'blackballed' from their surgery
(Jenny: G12 Single vaccine group).
5. "That doctor..." Andrew Wakefield as a credible source
While parents often spoke of concern about their own
doctor's presumed lack of impartiality, one particular doc-
tor at least was seen by some as an important and credible
source of information. For some, Andrew Wakefield was
an important whistle-blower and champion of ordinary
parents. More importantly he was perceived by some to
provide the necessary balance which they felt was often
missing from other accounts: "...at least Dr Wakefield has
stirred things up and got people asking questions" (Stella: G16
Parents of a child with autism). Criticism of Wakefield by
public health officials appeared counter-productive, and
if anything, was taken as evidence of their attempts to sup-
press the 'truth': "I just think the government lie about every-
thing... and try to discredit the doctors...you know, Wakefield"
(Angie: G7 High MMR uptake area group); "...instead of
saying 'no, no, not possible', they should take Dr. Wakefield's
work seriously" (Dawn: G3 Ante-natal group). For some,
Andrew Wakefield represented the voice of reason:" this
doctor who has had all these parents coming to him has said,
you know look, I'm not saying that it is a cause, but there is
enough concern to be worried about it" (Joanne: G2 First time
mothers group).
Not all parents agreed with this analysis. Some implied
that Wakefield should shoulder much of the blame for
their uncertainty about MMR safety:
"See, really, afore this all came out, that doctor, that doctor
should have had their facts perfect, the facts that they
should have been right before they came away out with all
this. It just seems as if they've blew it all out of proportion
and then they retract some of it". (Alan: G4 Low MMR
uptake area).
Discussion
These findings identify some of the problems which par-
ents perceive in identifying reliable sources of informa-
tion on MMR risks and benefits, and in balancing these to
make decisions about immunisation. Some viewed the
media as pivotal players in much of the unsettling dia-
logue played out in news reports in newspapers and on
the television, consistent with Clements and Ratzan's sug-
gestion that the media have been alarmist [13]. In con-
trast, other parents viewed the media as valuable sources
of evidence and seemed unquestioning about some of the
stories they heard and read. They also appeared to be
under the impression that there was as much evidence
showing a link, as showing no link, consistent with the
findings of the media analysis carried out by Hargreaves et
al. (2003). Parents spoke of feeling particularly drawn to
anecdotal stories involving real people, and spoke about
finding other parents' stories more convincing than statis-
tics and reassurances from scientists and politicians, per-
haps because, unlike doctors, they were perceived to have
no apparent conflicts of interest – only, quite naturally,
the interests of their own children. This suggests that for
public health communicators it may be better to make
judicial use of parents themselves to help communicate
with the public about MMR – and to use them not just as
providers of factual information on vaccine safety, but as
a way of explicitly acknowledging the difficulties and
dilemmas parents face.
Importantly, many parents appeared not to know whom
to trust to give impartial advice, and some were suspicious
of their GPs' motives. Whether parents trusted the infor-
mation health visitors gave depended on how well-
informed and open to debate they appeared to be. Con-
versely, ambiguous or entrenched views made parents less
trusting of the advice. Perhaps for this reason Andrew
Wakefield's apparent willingness to debate the issue of
vaccine safety made him seem more open and therefore
trustworthy to parents, than doctors who sounded too res-
olute about MMR safety. Indeed, any attempts to criticise
him and his research only appeared to serve to emphasise
his credentials as a "defender" of the rights and concerns
of ordinary parents. It is perhaps surprising for one indi-
vidual scientist or doctor to feature so strongly in public
accounts of a scientific controversy. The data presented in
this paper were collected before Wakefield's findings
became widely discredited, and before ten of his co-
authors published a retraction in the Lancet in 2004 [25].
Wakefield has however been placed back in the media eye
as a result of the General Medical Council investigation
[26] and if our research were to be repeated it would be
interesting to see whether his perceived trustworthiness
has been sustained.
A major strength of the study is that it includes an exten-
sive sample of parents representing a wide range of poten-
tial views on the MMR debate. This sampling strategy is
particularly useful when the aims is to gain an 'in-depth
understanding', rather than 'overall picture', of a topic.
Thus the sample is not intended to be statistically repre-
sentative and includes a higher proportion of vaccine
sceptics in order to gain new insights into parents' con-
cerns about the MMR debate. It is anticipated that the
findings in this paper will usefully contribute to the wider
debate about trust, credibility, conflict of interest, and to
understanding how to regain parental confidence in
childhood immunisation. However among the limita-
tions is the fact that the MMR debate is continuing to
develop and unfold, and parents' views may change in theBMC Public Health 2007, 7:42 http://www.biomedcentral.com/1471-2458/7/42
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light of new research, new campaigns and new media cov-
erage. There are also specific features which may make the
MMR controversy unusual, not least the emphasis on the
role of Wakefield as a source of evidence, and as a "par-
ents' champion". Nonetheless our findings bear out the
general conclusions of Brownlie and Howson (2005), that
in the case of MMR, trust in information providers is not
just about the quality of the information provided, but is
also about: "the wider socio-political changes...which par-
ents, professionals and indeed health authorities have to
negotiate"[17].
There are several implications for future research and
practice. The first relates to parents' perceptions of the
vested interests of health care professionals. Although par-
ents' satisfaction with health professionals with respect to
immunisation visits is high [27], some are suspicious of
the motives of GPs and health visitors, in part because of
their awareness of the Immunisation Target Payment sys-
tem. Both GPs and the Department of Health need to be
aware that patients' awareness of these fees may compro-
mise their value as sources of objective advice in the eyes
of parents, and the scheme may be potentially damaging
to the parent-practitioner relationship and to the achieve-
ment of vaccination targets. This may mean either that
such payments compromise trust to such an extent that
their use should be abandoned, or that communicators
should directly acknowledge that they exist and explain
their purpose.
A related point is that it is generally difficult for parents to
know who to trust to offer balanced and accurate informa-
tion on which they can make sound judgments. This has
general lessons for future education campaigns on immu-
nisation, which may require greater efforts to ensure that
patients are presented with information that is seen to be
reliable and unbiased. On the basis of the evidence pre-
sented in this paper, the potential downside of this is that
what health professionals see as "unbiased information"
may sometimes be viewed as unhelpful and non-directive,
or at worst reflecting a conflict of interest. This suggests
that in future campaigns risks, benefits and conflicts need
to be acknowledged clearly and openly, and that, as
acknowledged above, apparent conflicts of interest should
be addressed or explained where it is anticipated that
these will reduce public trust. This includes highlighting
to the public the financial conflicts of interest which
sometimes underlie the criticisms of apparently inde-
pendent scientific experts and critics.
Development of future effective communication strategies
may also usefully be informed by considering Lupton's
perspectives on risk and trust [28]. She suggests that when
people perceive 'expert knowledge' to be failing, they turn
to local knowledge to're-embed' their trust in those whom
they know personally. There was some evidence that par-
ents sought guidance from local knowledge by seeking
advice from their health visitors. However because health
visitors themselves seemed ambiguous about the safety of
MMR, parents questioned the extent to which they could
trust their advice. It is possible that some health visitors
were unable to reassure parents because they themselves
felt inadequately informed about new developments in
the MMR debate. The failure to reassure parents may also
reflect a wider a disparity between the expectations par-
ents and health visitors have of the role health visitors
play in childhood immunisation. What is needed is an
examination of health visitors' views of their role in the
MMR controversy in order to develop better guidance for
communicating public health messages to parents during
times of uncertainty. A stronger emphasis on building
trust than on providing more, or better information may
be needed [17]. Building trust involves health profession-
als becoming engaged in more open dialogue which
focuses attention on addressing parents' individual con-
cerns rather than on just providing factual information
about immunisation.
The issue of lack of trust may also be addressed by directly
confronting the issue of independence. The public may
value the opinions of MMR critics specifically because
they appear to offer independent, non-aligned expert
opinion, though they may not appreciate that these
experts too may be subject to conflicts of interest. Per-
ceived independence of professionals is known to be
important to the public in other spheres of risk communi-
cation [29], and in general doctors continue to be consid-
ered to be independent and trustworthy [30]; anything
that compromises independence therefore undermines
their role as communicators of risk. Miller and Macintyre
note that risk communication is not a one-off event, but a
continuing dialogue; and so although MMR coverage is
increasing, the need to ensure that communication with
the public about risks of vaccines and to build trust in pro-
fessionals remains. While "rebuilding trust" may seem a
somewhat paternalistic goal, it can also be consistent with
active patient involvement, and with greater concordance
[31].
Conclusion
The MMR debate continues to raise important and wide-
ranging issues in relation to perceived conflicts of interest,
and the lack of trust in providers of health information.
The General Medical Council's decision to formally disci-
pline Dr Wakefield in 2007 may bring about some sort of
resolution to the MMR debate. In the long term this con-
troversy may provide wider lessons for health profession-
als and governments about trust, credibility and risk
communication- lessons which may be applied to as yet
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